Published in Biotech Business Week, August 9th, 2004
Second-quarter 2004 revenues increased 33% to $11.3 million from $8.5 million during the same period of 2003. For the 6 months ended June 30, 2004, revenues were $21.7 million compared to $16.6 million in the same period of 2003, representing an increase of 31%.
Net income for the second quarter of 2004 increased 52% to $2.5 million, or $0.17 per diluted share, compared to $1.7 million, or $0.12 per diluted share in the prior year period.
For the 6 months ended June 30, 2004, net income was $5.1 million, or $0.32 per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.